Ubtech Robotics’ U1 Humanoid Pre-Orders Top 13,300, But Stock Stays Stuck Near Lows as Delivery Test Looms
Published on 07/09/2026 at 16:25 | Redaktion boerse-global.de
More than 13,300 pre-orders for a consumer humanoid robot that has yet to ship — and a stock price that has slumped nearly 32% since January. That is the stark gap facing Ubtech Robotics as it tries to convince investors that its pivot from industrial machines to emotional home companions is more than a headline.
The company unveiled the UWORLD U1 series at a launch event in Shenzhen in late June, marking its first serious foray into the mass market. The three-model lineup — U1 Lite, U1 Pro and U1 Ultra — ranges from 168 to 183 centimeters tall and weighs between 35 and 42 kilograms. Each unit features a biomimetic neck that mimics 90% of human motion, silicone skin, and 88 degrees of freedom. The core Resonance-LM AI model claims to detect over 20 emotional states — such as stress or fatigue — with an accuracy rate above 90% and a response time of under 500 milliseconds. Prices span 119,800 to 990,000 yuan (roughly $16,500 to $136,000 at current rates), targeting singles and elderly users in China. The company explicitly states the robots are meant for companionship, reminders, and emotional support — not household chores or intimate relationships.
Yet the market has greeted the product with a shrug — or worse. In Hong Kong, Ubtech shares (9880.HK) trade at 88.30 Hong Kong dollars, giving the company a market capitalisation of about 46.99 billion HKD. On a dual listing in Europe, the stock sits at €9.88, just 4.93% above its 52-week low of €9.42 and nearly 42% below its January peak of €17.00. The recent 30-day slide of more than a fifth has pushed the relative strength index to 39.5, and the shares are trading some 17% under their 50-day moving average of €11.87. Earnings per share remain deeply negative at -1.80 HKD, weighed down by heavy R&D spending on what the company calls “human-machine symbiosis”.
From Pre-Orders to Real Revenue
Ubtech claims pre-orders for the U1 series have already passed 13,300 — a dramatic jump from the 1,079 full-size humanoids it shipped in total in 2025. Founder Zhou Jian has set a target of 10,000 U1 units per year by the end of 2026, with first deliveries slated for September. But converting those orders into recognised revenue is the crux: the company has not yet disclosed binding contracts or down payments, and the stock’s persistent weakness suggests investors are pricing in execution risk rather than the launch story.
Should investors sell immediately? Or is it worth buying Ubtech Robotics?
The bull case rests on Ubtech opening a second growth engine alongside its established industrial robotics business. Zhou himself cited pre-orders already exceeding 10,000 units at the launch event, and the broader market backdrop is favourable. Morgan Stanley now expects China to ship 50,000 humanoid robots in 2026 — triple earlier estimates — and forecasts the global market will grow from $2 billion this year to $15 billion by 2030. If Ubtech can show smooth deliveries in the coming quarters, the current share price weakness could later be viewed as an overreaction.
Skepticism Runs Deep
Bearish voices point to the industry’s infancy. According to IDC, only around 18,000 humanoid robots were delivered worldwide in 2025, and less than 0.8% went to private households. More than 90% remained in industrial settings. Ubtech is trying to crack a consumer mass market with unproven hardware and no track record in home environments.
Competition is also heating up. Chinese rivals Unitree and Agibot have ramped up their own production in 2026, and at least one competitor has already launched a cheaper companion robot in the same emotional-AI segment, undercutting Ubtech’s entry price. That raises the spectre of rapid commoditisation in a still-niche category. Questions about long-term user engagement, data privacy, and ethical boundaries further cloud the outlook. On the technical front, the share’s RSI of 39.5 is not yet in oversold territory, suggesting further downside cannot be ruled out.
Ubtech Robotics at a turning point? This analysis reveals what investors need to know now.
Ubtech is not standing still. A joint venture with chipmaker Muxi aims to develop specialised silicon for embodied intelligence, securing the supply chain for future generations. The broader narrative positions the U1 series as a potential smartphone replacement — a central AI interface for daily life. But for now, the balance sheet tells a different story: 13,300 pre-orders meet a loss per share of -1.80 HKD.
What Comes Next
The next concrete milestone is the disclosure of actual U1 delivery volumes and consumer-segment revenue, expected to trickle out through the second half of 2026 as the June-launch roll-out transitions from order book to shipment. Until then, the pressure on the stock is likely to persist. A retest of the €9.42 low in Hong Kong terms — or the equivalent 88.30 HKD level — remains possible. Conversely, if Ubtech can demonstrate that its pre-orders are converting into paid deliveries, a recovery towards its 50-day average of €11.87 (roughly 105 HKD) would become plausible. In a year China has officially dubbed the “year of mass production” for humanoid robots, Ubtech must prove it can scale faster than its losses.
Ad
Ubtech Robotics Stock: New Analysis - 9 July
Fresh Ubtech Robotics information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
